CAS 1007476-63-2

Formula: C22H43F3LiO6P

InChI: InChI=1S/C22H44F3O6P.Li/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-29-18-21(31-32(26,27)28-2)19-30-20-22(23,24)25;/h21H,3-20H2,1-2H3,(H,26,27);/q;+1/p-1

InChI key: GDLMLQJISATCEL-UHFFFAOYSA-M

SMILES: [Li+].CCCCCCCCCCCCCCCCOCC(COCC(F)(F)F)OP(=O)([O-])OC

MJ33 lithium salt

CAS: 1007476-63-2

MJ33 lithium salt

Formula: C₂₂H₄₃F₃LiO₆P

Purezza: ≥98%

Peso molecolare: 498.48

Ref: 54-BUP22030

MJ33 (lithium salt)

CAS: 1007476-63-2

Purezza: 99%

Ref: IN-DA01DZBF

MJ33 lithium salt

CAS: 1007476-63-2

MJ33 lithium salt is an inhibitor of NADPH oxidase type 2-mediated ROS generation, inhibits PLA2 activity, and can be used to study acute lung injury.

Formula: C₂₂H₄₃F₃LiO₆P

Purezza: 99%

Colore e forma: Solid

Peso molecolare: 498.48

Ref: TM-T38404

Mj 33 lithium

CAS: 1007476-63-2

Mj 33 lithium is a potent and selective antibody that inhibits the activation of ion channels. It binds to the ligand-binding domain of receptors, preventing agonist binding and subsequent signal transduction. Mj 33 lithium has been shown to be an inhibitor of receptor tyrosine kinases, including type I insulin-like growth factor receptor (IGF1R), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor 2 (VEGFR2). It also has been shown to inhibit the activation of voltage-gated sodium channels in rat dorsal root ganglia neurons.

Formula: C₂₂H₄₄F₃LiO₆P

Purezza: Min. 95%

Peso molecolare: 499.5 g/mol

Ref: 3D-HQB47663